Close-up cross-section diagram of a hair follicle showing miniaturisation stages — from thick terminal hair to fine vellus hair — with clean medical illustration style on a white background. No faces.
Hair Loss
June 15, 2026
·
read

How DHT Miniaturises Hair Follicles: The Cellular Story

No items found.

If you've researched male hair loss, you've met three letters everywhere: DHT. It's central to the most common form of hair loss in men, yet how it actually works is often glossed over. At Noah, we think understanding the mechanism helps you grasp why certain approaches exist and why this is a medical matter best guided by a doctor. Here's the story, explained clearly.

This article is general education, not medical advice. A licensed Singapore doctor can assess your hair loss.

Meet DHT

DHT, or dihydrotestosterone, is a hormone derived from testosterone. The body converts a portion of testosterone into DHT via a specific enzyme. DHT has normal roles in the body, but it's also the key player in male pattern hair loss. The crucial point is that DHT doesn't affect everyone's hair the same way — its impact depends on whether a person's hair follicles are genetically sensitive to it.

The Role of Genetic Sensitivity

This is where genetics enters. In men with male pattern hair loss, certain hair follicles — typically along the hairline and crown — are genetically sensitive to DHT. The follicles elsewhere on the scalp tend to be more resistant, which is why pattern hair loss follows a recognisable shape rather than affecting the whole head evenly. So DHT is the trigger, but genetic susceptibility decides which follicles respond.

What "Miniaturisation" Means

In sensitive follicles, ongoing exposure to DHT is associated with a process called miniaturisation. Over successive hair cycles, affected follicles gradually produce finer, shorter, less robust hairs. What was once a thick, healthy strand becomes progressively thinner and weaker over time. Eventually, the hairs these follicles produce may become so fine that the area looks visibly thinner. This gradual shift, rather than sudden loss, is the hallmark of pattern hair loss.

Why It's Gradual and Patterned

Because miniaturisation unfolds over multiple hair cycles, pattern hair loss is typically slow and progressive rather than abrupt. And because only genetically sensitive follicles are affected, it follows the familiar pattern — receding hairline, thinning crown — while other areas remain comparatively unaffected. Understanding this explains why early changes can be subtle and why the pattern is so recognisable.

Why the Mechanism Matters for Treatment

Knowing that DHT drives miniaturisation in sensitive follicles explains why some medical approaches focus on the DHT pathway. Options a doctor may consider, such as finasteride, work by reducing DHT production. Because this is about a hormone-driven biological process in genetically susceptible men, it's firmly a medical matter — which is why any treatment requires a doctor's assessment and supervision rather than self-directed experimentation.

Why Early Changes Are Subtle

Because miniaturisation unfolds gradually over multiple hair cycles, early pattern hair loss can be subtle — finer, slightly weaker hairs rather than sudden bald patches. This is why changes can creep up unnoticed, particularly at the crown where they're harder to see. Understanding the gradual nature of the process explains why early signs are easy to miss and why noticing them is worthwhile. Catching changes earlier generally means more options, which is part of why getting thinning assessed sooner rather than later tends to be the more useful approach.

The Genetics-Plus-Hormones Picture

It's worth holding both parts of the mechanism in mind: genetics determine which follicles are sensitive, and DHT acts on that sensitivity. Neither alone tells the whole story — the two work together. This is why pattern hair loss runs in families yet still depends on the hormonal pathway, and why approaches that target DHT exist. Because it's a hormone-driven biological process in genetically susceptible men, it's firmly a medical matter. That's exactly why any treatment should be doctor-led rather than based on self-directed experimentation or online advice.

When to Speak to a Doctor

It's worth speaking to a licensed doctor if you've noticed a receding hairline, thinning at the crown, or gradual changes you're unsure about. A doctor can assess whether the pattern fits male pattern hair loss, explain the likely cause, and discuss which approaches are appropriate for your situation. Earlier assessment often means more options.

Hair loss treatments require medical assessment and, where relevant, prescription. Understanding the mechanism is helpful, but acting on it should be doctor-led.

Speak to a Licensed Doctor on Noah

If you want to understand and address your hair loss, a doctor can help. Noah connects you with MOH-licensed Singapore doctors through discreet, confidential online consultations. Start a consultation to discuss your hair loss.

This article is for general education and is not medical advice. A consultation with a licensed doctor is required before any treatment.

Close-up cross-section diagram of a hair follicle showing miniaturisation stages — from thick terminal hair to fine vellus hair — with clean medical illustration style on a white background. No faces.

At a glance

If you've researched male hair loss, you've met three letters everywhere: DHT. It's central to the most common form of hair loss in men, yet how it actually works is often glossed over.

References

Related reading

Find out what your BMI indicates

Your BMI indicates that you may be
Slider
BMI provides an estimate of weight classification. For a thorough analysis of your weight and medical options, arrange a teleconsult with a Noah doctor.

*Medical treatment may not be appropriate for you even if you have a high BMI
Your estimated weight loss in 1 year*
-
00
kg
-9%
90
kg
78
kg
99
81
63
Weight loss progress graph on transparent background showing treatment results
*In a 72-week clinical trial of 2,539 adults with obesity or overweight (without diabetes), participants taking the highest dose of GLP-1 + GIP alongside diet and exercise.
No items found.
Written by our Editorial Team
Last updated
15/6/2026
disclaimer